The use of experimental design in the optimization of risperidone biodegradable nanoparticles: in vitro and in vivo study

References

• Ahmed TA, El-Say KM. 2014. Development of alginate-reinforced chitosan nanoparticles utilizing W/O nanoemulsification/internal crosslinking technique for transdermal delivery of rabeprazole. Life Sci. 110:35–43.
   PubMed Web of Science ®Google Scholar
• Ahmed OAA, Ahmed TA, Abdel-naim AB, Khedr A, Banjar ZM, Afouna MI. 2014. Enhancement of in vitro skin transport and in vivo hypoglycemic efficacy of glimepiride transdermal patches. Trop J Pharm Res. 13:1207–1213.
   Web of Science ®Google Scholar
• Ahmed OAA, Hosny KM, Al-Sawahli MM, Fahmy UA. 2015. Optimization of caseinate-coated simvastatin-zein nanoparticles: improved bioavailability and modified release characteristics. Drug Des Devel Ther. 9:655–662.
   PubMed Web of Science ®Google Scholar
• Amass W, Amass A, Tighe B. 1998. A review of biodegradable polymers: uses, current developments in the synthesis and characterization of biodegradable polyesters, blends of biodegradable polymers and recent advances in biodegradation studies. Polym Int. 47:89–144.
   Web of Science ®Google Scholar
• Badr-Eldin SM, Ahmed TA, Ismail HR. 2013. Aripiprazole-cyclodextrin binary systems for dissolution enhancement: effect of preparation technique, cyclodextrin type and molar ratio. Iran J Basic Med Sci. 16:1223–1231.
   PubMed Web of Science ®Google Scholar
• Bodmeier R, McGinity JW. 1988. Solvent selection in the preparation of poly(dl-lactide) microspheres prepared by the solvent evaporation method. Int J Pharm. 43:179–186.
   Web of Science ®Google Scholar
• Cabovska B, Cox SL, Vinks AA. 2007. Determination of risperidone and enantiomers of 9-hydroxyrisperidone in plasma by LC-MS/MS. - in by -/. J Chromatogr B Analyt Technol Biomed Life Sci. 852:497–504.
   PubMed Web of Science ®Google Scholar
• Desai SJ, Singh P, Simonelli AP, Higuchi WI. 1966. Investigation of factors influencing release of solid drug dispersed in inert matrices. 3. Quantitative studies involving the polyethylene plastic matrix. J Pharm Sci. 55:1230–1234.
   PubMed Web of Science ®Google Scholar
• Feng S, Huang G. 2001. Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers. Taxolfrom nanospheres biodegradable. J Control Release. 71:53–69.
   PubMed Web of Science ®Google Scholar
• Ghadi A, Mahjoub S, Tabandeh F, Talebnia F. 2014. Synthesis and optimization of chitosan nanoparticles: potential applications in nanomedicine and biomedical engineering. Caspian J Intern Med. 5:156–161.
   PubMedGoogle Scholar
• Higuchi T. 1963. Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci. 52:1145–1149.
   PubMed Web of Science ®Google Scholar
• Huang ML, Peer AV, Woestenborghs R, De Coster R, Heykants J, Jansen AA, et al. 1993. Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjects. Clin Pharmacol Ther. 54:257–268.
   PubMed Web of Science ®Google Scholar
• Hutmacher DW, Schantz T, Zein I, Ng KW, Teoh SH, Tan KC. 2001. Mechanical properties and cell cultural response of polycaprolactone scaffolds designed and fabricated via fused deposition modeling. J Biomed Mater Res. 55:203–216.
   PubMed Web of Science ®Google Scholar
• Jalil R, Nixon JR. 1990. Biodegradable poly(lactic acid) and poly(lactide-co-glycolide) microcapsules: problems associated with preparative techniques and release properties. J Microencapsul. 7:297–325.
   PubMed Web of Science ®Google Scholar
• Jones T, Van Breda K, Charles B, Dean AJ, McDermott BM, Norris R. 2009. Determination of risperidone and 9-Hydroxyrisperidone using HPLC, in plasma of children and adolescents with emotional and behavioural disorders. Biomed Chromatogr. 23:929–934.
   PubMed Web of Science ®Google Scholar
• Kim BK, Hwang SJ, Park JB, Park HJ. 2002. Preparation and characterization of drug-loaded polymethacrylate microspheres by an emulsion solvent evaporation method. J Microencapsul. 19:811–822.
   PubMed Web of Science ®Google Scholar
• Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. 1983. Mechanisms of potassium chloride release from compressed, hydrophilic, polymeric matrices: effect of entrapped air. J Pharm Sci. 72:1189–1191.
   PubMed Web of Science ®Google Scholar
• Kwon HY, Lee JY, Choi SWJang YKim JH. 2001. Preparation of PLGA nanoparticles containing estrogen by emulsification–diffusion method. Coll Surfaces Physicochem Eng Asp. 182:123–130.
   Web of Science ®Google Scholar
• Marder SR. 2003. Overview of partial compliance. J Clin Psychiatry. 1:3–9. 64 Suppl.
   Google Scholar
• Mohanty AK, Misra M, Hinrichsen G. 2000. Biofibres, biodegradable polymers and biocomposites: an overview. Macromol Mater Eng. 276:1–24.
   Web of Science ®Google Scholar
• Murakami H, Kobayashi M, Takeuchi H, Kawashima Y. 1999. Preparation of poly(dl-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method. Int J Pharm. 187:143–152.
   PubMed Web of Science ®Google Scholar
• Muthu MS, Singh S. 2009. Poly (D, L-lactide) nanosuspensions of risperidone for parenteral delivery: formulation and in-vitro evaluation. Curr Drug Deliv. 6:62–68.
   PubMedGoogle Scholar
• Peppas NA. 1985. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv. 60:110–111.
   PubMedGoogle Scholar
• Quintanar-Guerrero D, Fessi H, Allémann E, Doelker A. 1996. Influence of stabilizing agents and preparative variables on the formation of poly(d,l-lactic acid) nanoparticles by an emulsification-diffusion technique. Int J Pharm. 143:133–141.
   Web of Science ®Google Scholar
• Rafati H, Coombes AG, Adler J, Holland J, Davis SS. 1997. Protein-loaded poly(dl-lactide-co-glycolide) microparticles for oral administration: formulation, structural and release characteristics. J Control Release. 43:89–102.
   Web of Science ®Google Scholar
• Ritger PL, Peppas NA. 1987. A Simple Equation for Description of Solute Release. II. Fickian and Anomalous Release from Swellable Devices. J Control Release. 5:1987.
   Google Scholar
• Sussman N. 2002. Choosing an atypical antipsychotic. Int Clin Psychopharmacol. 17 Suppl 3:S29–S33.
   PubMedGoogle Scholar
• Wagner JG. 1969. Interpretation of percent dissolved-time plots derived from in vitro testing of conventional tablets and capsules. J Pharm Sci. 58:1253–1257.
   PubMed Web of Science ®Google Scholar